Broadfin Capital LLC
Nom légal: BROADFIN CAPITAL, LLC
Coordonnées complètes
Broadfin Capital LLC
300 PARK AVENUE, 25TH FLOOR, NEW YORK, NY
212-808-2460
212-808-2464
Autre info
Broadfin Capital LLC, également connu sous le nom de BROADFIN CAPITAL, LLC, est une société à responsabilité limitée basée dans le Delaware. Avec cinq employés conseillers sur un total de dix employés, Broadfin Capital LLC sert trois clients, et son statut auprès de la SEC a été approuvé depuis le 28 mars 2012.
Broadfin Capital - Unique investment opportunities in the healthcare sector
Unique investment opportunities in the healthcare sector
Sucuri WebSite Firewall - Not Configured
Website Firewall Back to sucuri.net Sucuri Website Firewall - Not Configured The site you are visiting is using Sucuri Website Firewall. And for some reason it is not configured properly. If you are the site owner, please open a ticket here asap for us to look at it for you: https://support.sucuri.n…
Propriétaires directs
-
KEVIN KOTLER
MANAGING MEMBER possède 75% ou plus
-
NIR MESSAFI
CHIEF FINANCIAL OFFICER, CHIEF COMPLIANCE OFFICER possède Moins de 5%
Prime Brokers
-
J.P. MORGAN CLEARING CORP.
États Unis -
MORGAN STANLEY & CO. LLC
États Unis -
NATIONAL FINANCIAL SERVICES LLC
États Unis -
PERSHING LLC
États Unis -
UBS SECURITIES LLC
États Unis
Entreprises situées à proximité
- Turnbridge RE Fund Management Company I LLC
- HQ Capital Real Estate LP
- Rockefeller Financial LLC
- Radcliff Management LLC
- Franklin Templeton Institutional LLC
- RTW Investments LP
- Hanwha Asset Management USA Ltd
- OFI Global Asset Management Inc
- Dekania Capital Management LLC
- Blackstone Real Estate Advisors International LLC
Principaux fonds
- Iovance Biotherapeutics Inc $38,234k
- ARATANA THERAPEUTICS INC $37,452k
- NEVRO CORP COM $31,654k
- MIRATI THERAPEUTICS INC $20,600k
- BIODELIVERY SCI INTL $19,911k
- ALLERGAN PLC $19,222k
- Eiger Biopharmaceuticals Inc $17,555k
- BIOHAVEN PHARMACTL HLDG CO L $17,516k
- GLOBAL BLOOD THERAPEUTICS IN $16,654k
- ZOGENIX INC $16,473k